62
https://pubmed.ncbi.nlm.nih.gov/38117940
Sulfathiazole-triazolo chalcone hybrids show potential as anticancer agents by inhibiting VEGFR-2 and EGFR kinases, and inducing apoptosis in cancer cells.
https://pubmed.ncbi.nlm.nih.gov/38117940
Sulfathiazole-triazolo chalcone hybrids show potential as anticancer agents by inhibiting VEGFR-2 and EGFR kinases, and inducing apoptosis in cancer cells.